西安瑞联新材料股份有限公司2025年度业绩快报公告

Financial Performance - In 2025, the company achieved operating revenue of 1,676.75 million yuan, representing a year-on-year increase of 14.95% [3] - The net profit attributable to the parent company was 310.83 million yuan, up 23.48% year-on-year [3] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 305.98 million yuan, reflecting a year-on-year growth of 28.90% [3] Financial Position - As of the end of the reporting period, the company's total assets amounted to 3,646.89 million yuan, an increase of 7.33% from the beginning of the period [4] - The equity attributable to the parent company reached 3,285.55 million yuan, growing by 8.60% compared to the start of the period [4] - The net asset per share attributable to the parent company was 18.93 yuan, which is a 9.32% increase from the beginning of the period [4] Business Performance Factors - The growth in revenue for 2025 was primarily driven by the pharmaceutical and electronic materials sectors, with the pharmaceutical sector benefiting from inventory adjustments by key clients and increased sales of core products [5] - The electronic materials sector saw growth due to successful validation of semiconductor photoresist monomer materials and the introduction of certain packaging materials [5] - The company focused on enhancing operational efficiency and cost reduction, which contributed to improved profitability [5]